Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease

C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting

(2013) Rolf P. Kreutz et al.   BLOOD COAGULATION & FIBRINOLYSIS

Large-scale association analysis identifies new risk loci for coronary artery disease

(2012) Panos Deloukas et al.   NATURE GENETICS

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

(2011) Matthew J. Price   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions

(2011) S. G. MAGWENZI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

FXIII-A Leu34 genetic variant in premature coronary artery disease: A genotype – phenotype case control study

(2011) Johanne Silvain et al.   THROMBOSIS AND HAEMOSTASIS

Factor XIII, clot structure, thrombosis

(2011) Zsuzsa Bagoly et al.   THROMBOSIS RESEARCH

Stent Thrombosis

(2010) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic RIsk Progression (TRIP) Study

(2010) Udaya S. Tantry et al.   PLATELETS

Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

(2010) Francisco Marín et al.   THROMBOSIS AND HAEMOSTASIS

C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation

(2009) Duk-Woo Park et al.   CIRCULATION

Inflammation in Atherosclerosis

(2009) Peter Libby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

The link between heightened thrombogenicity and inflammation: Pre-procedure characterization of the patient at high risk for recurrent events after stenting

(2009) Paul A. Gurbel et al.   PLATELETS

Polyphosphate as a general procoagulant agent

(2008) S. A. SMITH et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS